Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

A Study in Healthy Volunteers and Patients With Chronic Hepatitis B
A Randomized, Partially-blinded, Placebo-controlled, Ascending Sequential Dose Groups, Single Dose Study of the Safety, Tolerability and Pharmacokinetics of CRV431, Alone and In Combination With Tenofovir Disoproxil Fumarate in Healthy Subjects, With a Pilot Study of Multiple Ascending Sequential Doses in HBV-Infected Subjects on Chronic Tenofovir Disoproxil Fumarate Treatment
Status: Enrolling
Updated:  12/31/1969
Celerion
mi
from
Tempe, AZ
A Study in Healthy Volunteers and Patients With Chronic Hepatitis B
A Randomized, Partially-blinded, Placebo-controlled, Ascending Sequential Dose Groups, Single Dose Study of the Safety, Tolerability and Pharmacokinetics of CRV431, Alone and In Combination With Tenofovir Disoproxil Fumarate in Healthy Subjects, With a Pilot Study of Multiple Ascending Sequential Doses in HBV-Infected Subjects on Chronic Tenofovir Disoproxil Fumarate Treatment
Status: Enrolling
Updated: 12/31/1969
Celerion
mi
from
Tempe, AZ
Click here to add this to my saved trials
A Study in Healthy Volunteers and Patients With Chronic Hepatitis B
A Randomized, Partially-blinded, Placebo-controlled, Ascending Sequential Dose Groups, Single Dose Study of the Safety, Tolerability and Pharmacokinetics of CRV431, Alone and In Combination With Tenofovir Disoproxil Fumarate in Healthy Subjects, With a Pilot Study of Multiple Ascending Sequential Doses in HBV-Infected Subjects on Chronic Tenofovir Disoproxil Fumarate Treatment
Status: Enrolling
Updated:  12/31/1969
Celerion
mi
from
Lincoln, NE
A Study in Healthy Volunteers and Patients With Chronic Hepatitis B
A Randomized, Partially-blinded, Placebo-controlled, Ascending Sequential Dose Groups, Single Dose Study of the Safety, Tolerability and Pharmacokinetics of CRV431, Alone and In Combination With Tenofovir Disoproxil Fumarate in Healthy Subjects, With a Pilot Study of Multiple Ascending Sequential Doses in HBV-Infected Subjects on Chronic Tenofovir Disoproxil Fumarate Treatment
Status: Enrolling
Updated: 12/31/1969
Celerion
mi
from
Lincoln, NE
Click here to add this to my saved trials
A Study in Healthy Volunteers and Patients With Chronic Hepatitis B
A Randomized, Partially-blinded, Placebo-controlled, Ascending Sequential Dose Groups, Single Dose Study of the Safety, Tolerability and Pharmacokinetics of CRV431, Alone and In Combination With Tenofovir Disoproxil Fumarate in Healthy Subjects, With a Pilot Study of Multiple Ascending Sequential Doses in HBV-Infected Subjects on Chronic Tenofovir Disoproxil Fumarate Treatment
Status: Enrolling
Updated:  12/31/1969
Schiff Center for Liver Diseases/University of Miami
mi
from
Miami, FL
A Study in Healthy Volunteers and Patients With Chronic Hepatitis B
A Randomized, Partially-blinded, Placebo-controlled, Ascending Sequential Dose Groups, Single Dose Study of the Safety, Tolerability and Pharmacokinetics of CRV431, Alone and In Combination With Tenofovir Disoproxil Fumarate in Healthy Subjects, With a Pilot Study of Multiple Ascending Sequential Doses in HBV-Infected Subjects on Chronic Tenofovir Disoproxil Fumarate Treatment
Status: Enrolling
Updated: 12/31/1969
Schiff Center for Liver Diseases/University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
A Study in Healthy Volunteers and Patients With Chronic Hepatitis B
A Randomized, Partially-blinded, Placebo-controlled, Ascending Sequential Dose Groups, Single Dose Study of the Safety, Tolerability and Pharmacokinetics of CRV431, Alone and In Combination With Tenofovir Disoproxil Fumarate in Healthy Subjects, With a Pilot Study of Multiple Ascending Sequential Doses in HBV-Infected Subjects on Chronic Tenofovir Disoproxil Fumarate Treatment
Status: Enrolling
Updated:  12/31/1969
Axis Clinical Trials
mi
from
Los Angeles, CA
A Study in Healthy Volunteers and Patients With Chronic Hepatitis B
A Randomized, Partially-blinded, Placebo-controlled, Ascending Sequential Dose Groups, Single Dose Study of the Safety, Tolerability and Pharmacokinetics of CRV431, Alone and In Combination With Tenofovir Disoproxil Fumarate in Healthy Subjects, With a Pilot Study of Multiple Ascending Sequential Doses in HBV-Infected Subjects on Chronic Tenofovir Disoproxil Fumarate Treatment
Status: Enrolling
Updated: 12/31/1969
Axis Clinical Trials
mi
from
Los Angeles, CA
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Winston Technology Research, LLC
mi
from
Haleyville, AL
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Winston Technology Research, LLC
mi
from
Haleyville, AL
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Boyett Health Services
mi
from
Hamilton, AL
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Boyett Health Services
mi
from
Hamilton, AL
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Behavioral Research Specialists, LLC
mi
from
Glendale, CA
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Behavioral Research Specialists, LLC
mi
from
Glendale, CA
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Collaborative Neuroscience Networks, Inc.
mi
from
Long Beach, CA
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Collaborative Neuroscience Networks, Inc.
mi
from
Long Beach, CA
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Synergy Research Center
mi
from
National City, CA
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Synergy Research Center
mi
from
National City, CA
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
North County Clinical Research
mi
from
Oceanside, CA
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
North County Clinical Research
mi
from
Oceanside, CA
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Artemis Institute for Clinical Research
mi
from
San Diego, CA
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Amit Vijapura
mi
from
Jacksonville, FL
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Amit Vijapura
mi
from
Jacksonville, FL
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Meridien Research
mi
from
Lakeland, FL
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Meridien Research
mi
from
Lakeland, FL
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Try Research
mi
from
Maitland, FL
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Try Research
mi
from
Maitland, FL
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Innovative Clinical Research
mi
from
Miami, FL
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Innovative Clinical Research
mi
from
Miami, FL
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Scientific Clinical Research Inc.
mi
from
Miami, FL
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Scientific Clinical Research Inc.
mi
from
Miami, FL
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Research Centers of America, LLC
mi
from
Oakland Park, FL
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Research Centers of America, LLC
mi
from
Oakland Park, FL
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Louisiana Research Associates, Inc.
mi
from
New Orleans, LA
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Louisiana Research Associates, Inc.
mi
from
New Orleans, LA
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Louisiana Clinical Research
mi
from
Shreveport, LA
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Louisiana Clinical Research
mi
from
Shreveport, LA
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Stanley Street Treatment and Resources
mi
from
Fall River, MA
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Stanley Street Treatment and Resources
mi
from
Fall River, MA
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Adams Clinical Trials LLC
mi
from
Watertown, MA
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Adams Clinical Trials LLC
mi
from
Watertown, MA
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Precise Research Centers
mi
from
Flowood, MS
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Precise Research Centers
mi
from
Flowood, MS
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
St. Louis Clinical Trials, LLC
mi
from
Saint Louis, MO
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
St. Louis Clinical Trials, LLC
mi
from
Saint Louis, MO
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Altea Research Institute
mi
from
Las Vegas, NV
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Altea Research Institute
mi
from
Las Vegas, NV
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Hassman Research Institute
mi
from
Berlin, NJ
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Hassman Research Institute
mi
from
Berlin, NJ
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Center For Emotional Fitness
mi
from
Cherry Hill, NJ
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Center For Emotional Fitness
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
The Medical Research Network, LLC
mi
from
New York, NY
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
The Medical Research Network, LLC
mi
from
New York, NY
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Neuro-Behavioral Clinical Research, Inc.
mi
from
Canton, OH
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Neuro-Behavioral Clinical Research, Inc.
mi
from
Canton, OH
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Midwest Clinical Research Center
mi
from
Dayton, OH
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Charak Clinical Research Center
mi
from
Garfield Heights, OH
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Charak Clinical Research Center
mi
from
Garfield Heights, OH
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Oklahoma Clinical Research Center
mi
from
Oklahoma City, OK
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Oklahoma Clinical Research Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Pahl Pharmaceutical Professionals, LLC
mi
from
Oklahoma City, OK
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Pahl Pharmaceutical Professionals, LLC
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
CODA, Inc.
mi
from
Portland, OR
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
CODA, Inc.
mi
from
Portland, OR
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Tipton Medical and Diagnostic Center aka Clinical Research Associates of Central PA
mi
from
Altoona, PA
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Tipton Medical and Diagnostic Center aka Clinical Research Associates of Central PA
mi
from
Altoona, PA
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
UPenn Treatment Research Center
mi
from
Philadelphia, PA
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
UPenn Treatment Research Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Carolina Clinical Trials, Inc.
mi
from
Charleston, SC
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Carolina Clinical Trials, Inc.
mi
from
Charleston, SC
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
Pillar Clinic Research, LLC
mi
from
Dallas, TX
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
Pillar Clinic Research, LLC
mi
from
Dallas, TX
Click here to add this to my saved trials
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated:  12/31/1969
InSite Clinical Research LLC
mi
from
DeSoto, TX
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery—The RECOVER Study®
Status: Enrolling
Updated: 12/31/1969
InSite Clinical Research LLC
mi
from
DeSoto, TX
Click here to add this to my saved trials
A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed 4-weekly), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Completed Studies CDP870-031 or CDP870-032
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Birmingham, AL
A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed 4-weekly), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Completed Studies CDP870-031 or CDP870-032
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed 4-weekly), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Completed Studies CDP870-031 or CDP870-032
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Huntsville, AL
A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed 4-weekly), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Completed Studies CDP870-031 or CDP870-032
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed 4-weekly), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Completed Studies CDP870-031 or CDP870-032
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tucson, AZ
A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed 4-weekly), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Completed Studies CDP870-031 or CDP870-032
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed 4-weekly), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Completed Studies CDP870-031 or CDP870-032
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Orange, CA
A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed 4-weekly), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Completed Studies CDP870-031 or CDP870-032
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed 4-weekly), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Completed Studies CDP870-031 or CDP870-032
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
San Diego, CA
A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed 4-weekly), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Completed Studies CDP870-031 or CDP870-032
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed 4-weekly), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Completed Studies CDP870-031 or CDP870-032
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Colorado Springs, CO
A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed 4-weekly), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Completed Studies CDP870-031 or CDP870-032
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed 4-weekly), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Completed Studies CDP870-031 or CDP870-032
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Gainesville, FL
A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed 4-weekly), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Completed Studies CDP870-031 or CDP870-032
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed 4-weekly), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Completed Studies CDP870-031 or CDP870-032
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Jacksonville, FL
A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed 4-weekly), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Completed Studies CDP870-031 or CDP870-032
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed 4-weekly), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Completed Studies CDP870-031 or CDP870-032
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Miami, FL
A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed 4-weekly), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Completed Studies CDP870-031 or CDP870-032
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed 4-weekly), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Completed Studies CDP870-031 or CDP870-032
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Plantation, FL
A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed 4-weekly), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Completed Studies CDP870-031 or CDP870-032
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Plantation, FL
Click here to add this to my saved trials
A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed 4-weekly), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Completed Studies CDP870-031 or CDP870-032
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed 4-weekly), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Completed Studies CDP870-031 or CDP870-032
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials